1-8 of 8
Muneyoshi Futami, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Mouse Homolog of Mutant Wasp Responsible for X-Linked Neutropenia Causes Reduced Myeloid Progenitor Activity but Rather Increased Neutrophil Compartment in Bone Marrow

Masahiro Ikeda, Muneyoshi Futami, MD PhD, Bidisha Chanda, MD PhD, Masayuki Kobayashi, MD PhD, Kiyoko Izawa, PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-139059
Published: 2020
Journal Articles

Combined Inhibition of HDAC and AKT As a Strategy to Overcome Multi-Drug Resistance in Patients with Multiple Myeloma

Mitsuhito Hirano, MD, Yoichi Imai, MD PhD, Takahiko Murayama, PhD, Kota Sato, MD PhD, Junichi Yamamoto, PhD, Takumi Ito, PhD, Muneyoshi Futami, MD PhD, Masaki Ri, Hiroshi Yasui, MD PhD, Noriko Gotoh, MD, Shinsuke Iida, MD PhD, Tadao Ishida, MD PhD, Hiroshi Handa, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4325.
https://doi.org/10.1182/blood-2019-122662
Published: 2019
Journal Articles

Therapeutic Targeting of Monokine Production Is a Promising Strategy to Attenuate Cytokine-Release Syndrome in CAR-T Cell Therapy

Muneyoshi Futami, MD PhD, Keisuke Suzuki, MS, Satomi Kato, BS, Yoshio Tahara, MS, Yoichi Imai, MD PhD, Takayuki Mimura, PhD, Yoshihiro Watanabe, PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2067.
https://doi.org/10.1182/blood-2019-129601
Published: 2019
Journal Articles

Histone Deacetylase Inhibitors with or without AKT Inhibition Potentially Increase the Efficacy of Daratumumab in Multiple Myeloma By Enhancing the Antibody-Dependent Cell-Mediated and Complement-Dependent Cytotoxicity As Well As Apoptosis

Mitsuhito Hirano, MD, Yoichi Imai, MD PhD, Weng-Chit Ung, MSc, Kota Sato, MD PhD, Muneyoshi Futami, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4435.
https://doi.org/10.1182/blood-2018-99-110709
Published: 2018
Journal Articles

Evaluation of Oncolytic Viral Therapy Combined with or without Artificial Immunoadjuvant Cell Therapy in Immunocompetent Mouse Tumor Models

Weng-Chit Ung, MSc, Muneyoshi Futami, MD PhD, Kota Sato, MDPhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5793.
https://doi.org/10.1182/blood-2018-99-112789
Published: 2018
Journal Articles

A Novel Mutant Wasp in X-Linked Neutropenia Partially Recapitulates Defective Neutrophil Production through Its Expression in WASP-Deficient NB4 Cells

Masayuki Kobayashi, MD, Bidisha Chanda, MD PhD, Muneyoshi Futami, MD PhD, Mizuho Yamashita, Mitsuhito Hirano, MD, Kazuaki Yokoyama, MD PhD, Yoichi Imai, MDPhD, Eigo Shimizu, Nozomi Yusa, Rui Yamaguchi, PhD, Seiya Imoto, PhD, Satoru Miyano, PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3560.
https://doi.org/10.1182/blood.V130.Suppl_1.3560.3560
Published: 2017
Journal Articles

Feasibility of a Cell-Based Oncolytic Virotherapy Targeting Bone Marrow Lesions of Multiple Myeloma

Kota Sato, MD, Muneyoshi Futami, MD PhD, Ung Weng Chit, Takafumi Nakamura, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4499.
https://doi.org/10.1182/blood.V128.22.4499.4499
Published: 2016
Journal Articles

The G-CSF Receptor Requires Gab2-Mediated Recruitment of the Tyrosine Phosphatase Shp2 to Promote Lyn-Dependent Proliferation.

Muneyoshi Futami, MD, PhD, Quan-Sheng Zhu, MD, PhD, Gen-Sheng Feng, Benjamin Neel, MD, PhD, Seth J. Corey, MD
Journal: Blood
Blood (2010) 116 (21): 1555.
https://doi.org/10.1182/blood.V116.21.1555.1555
Published: 2010